The pharmaceutical company raised its sales and operating profit guidance for 2014, as it posted a smaller than expected rise in fourth quarter net profit.
via WSJ.com: US Business http://ift.tt/1fhZULp
via WSJ.com: US Business http://ift.tt/1fhZULp
Nessun commento:
Posta un commento